Historical record - last NADAC publication: 5/20/2015
Product Information
ADT ROBITUSSIN PEAK CLD M-S LQ is a brand product labeled by Haleon US Holdings LLC, priced at $0.0368 per ML under NDC 00031874214. Its NADAC has been published 97 times since Nov 28, 2013.
ADT ROBITUSSIN PEAK CLD M-S LQ
dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochlorideStrength
10; 100; 5 mg/5mL; mg/5mL; mg/5mL
Manufacturer
Haleon US Holdings LLCNDC
00031874214
Classification
Brand
Dosage Form
LIQUID
Route
ORAL
Last Updated
5/20/2015
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
6/12/2011
Pharmacological Classes
Price Statistics
The NADAC for ADT ROBITUSSIN PEAK CLD M-S LQ has been published 97 times since Nov 28, 2013, and over the history we have for it it has risen 2.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0368 per ML |
|---|---|
| All-time high | $0.0385 (Apr 15, 2015) |
| All-time low | $0.0349 (Sep 17, 2014) |
| Median price | $0.0368 |
| Average price | $0.0365 |
| Largest weekly change | +6.4% (Nov 19, 2014) |
| Weeks tracked | 97 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ADT ROBITUSSIN PEAK CLD M-S LQ?
The current National Average Drug Acquisition Cost (NADAC) for ADT ROBITUSSIN PEAK CLD M-S LQ, manufactured by Haleon US Holdings LLC, is $0.0368 per ML (NDC 00031874214), effective Sep 30, 2015.
How has the price of ADT ROBITUSSIN PEAK CLD M-S LQ changed over time?
Over the history we have for it, the NADAC for ADT ROBITUSSIN PEAK CLD M-S LQ has risen 2.4%. It has been tracked across 97 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ADT ROBITUSSIN PEAK CLD M-S LQ?
Since Nov 28, 2013, the NADAC for ADT ROBITUSSIN PEAK CLD M-S LQ has ranged from a low of $0.0349 (Sep 17, 2014) to a high of $0.0385 (Apr 15, 2015), with a median of $0.0368 per ML.
Are there cheaper alternatives to ADT ROBITUSSIN PEAK CLD M-S LQ?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, ADT ROBITUSSIN PEAK CLD M-S LQ, is $0.0284 per ML — about 23% below ADT ROBITUSSIN PEAK CLD M-S LQ.
Who manufactures ADT ROBITUSSIN PEAK CLD M-S LQ?
ADT ROBITUSSIN PEAK CLD M-S LQ (NDC 00031874214) is labeled by Haleon US Holdings LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification